ENOGIA SAS (ALENO.PA) Fundamental Analysis & Valuation

EPA:ALENO • FR0014004974

Current stock price

5.84 EUR
+0.08 (+1.39%)
Last:

This ALENO.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALENO.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALENO has reported negative net income.
  • In the past 5 years ALENO always reported negative net income.
  • ALENO had a negative operating cash flow in each of the past 5 years.
ALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

  • ALENO has a Return On Assets (-1.98%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of -5.59%, ALENO is in line with its industry, outperforming 41.10% of the companies in the same industry.
Industry RankSector Rank
ROA -1.98%
ROE -5.59%
ROIC N/A
ROA(3y)-15.16%
ROA(5y)-16.28%
ROE(3y)-43.3%
ROE(5y)-107.28%
ROIC(3y)N/A
ROIC(5y)N/A
ALENO.PA Yearly ROA, ROE, ROICALENO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

  • ALENO has a better Gross Margin (114.85%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of ALENO has declined.
  • The Profit Margin and Operating Margin are not available for ALENO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 114.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y-12.18%
ALENO.PA Yearly Profit, Operating, Gross MarginsALENO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALENO.PA Health Analysis

2.1 Basic Checks

  • ALENO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALENO has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALENO has more shares outstanding
  • The debt/assets ratio for ALENO is higher compared to a year ago.
ALENO.PA Yearly Shares OutstandingALENO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALENO.PA Yearly Total Debt VS Total AssetsALENO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • ALENO has an Altman-Z score of 1.85. This is not the best score and indicates that ALENO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALENO has a Altman-Z score of 1.85. This is comparable to the rest of the industry: ALENO outperforms 49.32% of its industry peers.
  • ALENO has a Debt/Equity ratio of 0.80. This is a neutral value indicating ALENO is somewhat dependend on debt financing.
  • ALENO has a Debt to Equity ratio of 0.80. This is in the lower half of the industry: ALENO underperforms 67.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF N/A
Altman-Z 1.85
ROIC/WACCN/A
WACC8.88%
ALENO.PA Yearly LT Debt VS Equity VS FCFALENO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • ALENO has a Current Ratio of 1.28. This is a normal value and indicates that ALENO is financially healthy and should not expect problems in meeting its short term obligations.
  • ALENO has a Current ratio (1.28) which is in line with its industry peers.
  • ALENO has a Quick Ratio of 1.27. This is a normal value and indicates that ALENO is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALENO (1.27) is better than 72.60% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.27
ALENO.PA Yearly Current Assets VS Current LiabilitesALENO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ALENO.PA Growth Analysis

3.1 Past

  • ALENO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.02%, which is quite impressive.
  • Looking at the last year, ALENO shows a very strong growth in Revenue. The Revenue has grown by 55.69%.
  • The Revenue has been growing by 25.85% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)59.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.01%
Revenue 1Y (TTM)55.69%
Revenue growth 3Y39.7%
Revenue growth 5Y25.85%
Sales Q2Q%50.81%

3.2 Future

  • The Earnings Per Share is expected to grow by 91.29% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALENO will show a very strong growth in Revenue. The Revenue will grow by 40.10% on average per year.
EPS Next Y200%
EPS Next 2Y123.61%
EPS Next 3Y91.29%
EPS Next 5YN/A
Revenue Next Year62.5%
Revenue Next 2Y45.77%
Revenue Next 3Y40.1%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALENO.PA Yearly Revenue VS EstimatesALENO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
ALENO.PA Yearly EPS VS EstimatesALENO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALENO.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALENO. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 18.90, the valuation of ALENO can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, ALENO is valued a bit cheaper than 73.97% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. ALENO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 18.9
ALENO.PA Price Earnings VS Forward Price EarningsALENO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALENO.PA Per share dataALENO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALENO's earnings are expected to grow with 91.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.61%
EPS Next 3Y91.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALENO.PA Dividend Analysis

5.1 Amount

  • ALENO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALENO.PA Fundamentals: All Metrics, Ratios and Statistics

ENOGIA SAS

EPA:ALENO (3/13/2026, 7:00:00 PM)

5.84

+0.08 (+1.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners6.52%
Inst Owner ChangeN/A
Ins Owners22.47%
Ins Owner ChangeN/A
Market Cap36.73M
Revenue(TTM)9.85M
Net Income(TTM)-419.00K
Analysts86.67
Price Target7.14 (22.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)27.27%
PT rev (3m)27.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)8.33%
Revenue NY rev (3m)8.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.9
P/S 3.73
P/FCF N/A
P/OCF N/A
P/B 4.9
P/tB 55.41
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.31
Fwd EY5.29%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.57
BVpS1.19
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.98%
ROE -5.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 114.85%
FCFM N/A
ROA(3y)-15.16%
ROA(5y)-16.28%
ROE(3y)-43.3%
ROE(5y)-107.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y-12.18%
F-ScoreN/A
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.27
Altman-Z 1.85
F-ScoreN/A
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.01%
EPS Next Y200%
EPS Next 2Y123.61%
EPS Next 3Y91.29%
EPS Next 5YN/A
Revenue 1Y (TTM)55.69%
Revenue growth 3Y39.7%
Revenue growth 5Y25.85%
Sales Q2Q%50.81%
Revenue Next Year62.5%
Revenue Next 2Y45.77%
Revenue Next 3Y40.1%
Revenue Next 5YN/A
EBIT growth 1Y20.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year300%
EBIT Next 3Y91.29%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ENOGIA SAS / ALENO.PA Fundamental Analysis FAQ

What is the fundamental rating for ALENO stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALENO.PA.


What is the valuation status for ALENO stock?

ChartMill assigns a valuation rating of 3 / 10 to ENOGIA SAS (ALENO.PA). This can be considered as Overvalued.


Can you provide the profitability details for ENOGIA SAS?

ENOGIA SAS (ALENO.PA) has a profitability rating of 1 / 10.


How financially healthy is ENOGIA SAS?

The financial health rating of ENOGIA SAS (ALENO.PA) is 3 / 10.


Can you provide the expected EPS growth for ALENO stock?

The Earnings per Share (EPS) of ENOGIA SAS (ALENO.PA) is expected to grow by 200% in the next year.